LOS
ANGELES, May 29, 2024 /PRNewswire/ -- Aadi
Bioscience, Inc. (NASDAQ: AADI), a commercial-stage precision
oncology company focused on developing and commercializing
therapies for cancers with alterations in the mTOR pathway,
announced today participation in the Jefferies Healthcare
Conference, taking place June 5-6, 2024, in New
York. Dave Lennon, Ph.D., President and CEO, will
participate in a fireside chat on Wednesday, June 5, 2024,
from 2:00 PM – 2:25 PM EDT.
The fireside chat will be webcast live on the IR pages of
the Aadi Bioscience website and will be available
for replay for approximately 30 days following each investor
event.
About Aadi Bioscience, Inc.
Aadi is a commercial-stage precision oncology company focused on
the development and commercialization of therapies for cancers with
alterations in the mTOR pathway, a key regulator of cell growth and
cancer progression. To unlock the full potential of mTOR
inhibition, Aadi uniquely combines nanoparticle albumin-bound
(nab) technology with the potent mTOR inhibitor, sirolimus.
Aadi received FDA approval and commercializes FYARRO® for the
treatment of adult patients with locally advanced unresectable or
metastatic malignant perivascular epithelioid cell tumor
(PEComa).
Aadi is exploring nab-sirolimus in PRECISION1, a Phase 2
tumor-agnostic registration-intended trial in mTOR inhibitor-naïve
malignant solid tumors harboring TSC1 or TSC2
inactivating alterations. Aadi is also exploring
nab-sirolimus in two single-indication Phase 2 trials for
difficult-to-treat mTOR-driven cancers: neuroendocrine tumors
(NETs), and advanced or recurrent endometrioid-type endometrial
cancer (EEC) in combination with letrozole. More information on
Aadi's development pipeline is available on the Aadi website at
www.aadibio.com and connect with us on Twitter and LinkedIn.
Contact:
IR@aadibio.com
View original content to download
multimedia:https://www.prnewswire.com/news-releases/aadi-bioscience-to-participate-in-the-jefferies-healthcare-conference-302158555.html
SOURCE Aadi Bioscience